Page 70 - SPONDYLOARTHRITIS IN COLOMBIA -

The objective of this study was (1) to determine the prevalence of -and the risks to present - comorbidities as assessed in the ASAS-COMOSPA-study –used as a reference group- in patients with SpA in three LA countries; and (2) to compare the prevalence of these with the information in the general population, in order to find out if the prevalence of -and the risk on -comorbidities is increased.
METHODS
Study design and patient recruitment
This was a cross-sectional study that used data from the worldwide ASAS-COMOSPA-study 12. Briefly, the ASAS-COMOSPA-study was an observational, multicenter and international study (22 countries from four continents) that included consecutive adult patients who fulfilled the ASAS SpA-criteria (axial or peripheral). The patients in the ASAS-COMOSPA-study enrolled from Argentina, Colombia and Mexico (one academic center in each country) were selected and analyzed for the present study. Additionally, 47 Colombian patients with data that made them eligible to ASAS-COMPOSPA but that were offered after the electronic database for the international study had been locked, were also included in this analysis. The results in which the Global ASAS-COMOSPA study data are reported in this study include the data from the LA countries. The study was approved by the Ethics and Research Committee of the Hospital Militar (No.C-2014-027) and was conducted according to the guidelines for good clinical-practice. All patients sign the informed-consent.
Data collection
Details of the data collection methods have been published previously 12. A case report form was used in the study to collect the data including patient’s demographics, SpA disease characteristics and extra-articular manifestations (uveitis, psoriasis, IBD). Information about past and current
68